# Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument

> **NCT01841762** · PHASE3 · COMPLETED · sponsor: **Actelion** · enrollment: 284 (actual)

## Conditions studied

- Pulmonary Arterial Hypertension

## Interventions

- **DRUG:** Macitentan

## Key facts

- **NCT ID:** NCT01841762
- **Lead sponsor:** Actelion
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04-01
- **Primary completion:** 2015-11-01
- **Final completion:** 2015-11-01
- **Target enrollment:** 284 (ACTUAL)
- **Last updated:** 2019-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01841762

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01841762, "Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT01841762. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*